동의신경정신과학회지 (Journal of Oriental Neuropsychiatry)

  • 제33권4호
  • /
  • Pages.377-388
  • /
  • 2022
  • /
  • 1226-6396(pISSN)
  • /
  • 2234-4942(eISSN)
대한한방신경정신과학회 (The Korean Society of Oriental Neuropsychiatry)
권호 표지
DOI QR코드

DOI QR Code

CP 기반 정신 평가 및 진단을 위한 심리검사의 활용

Utilization of Psychological Tools for Critical Pathway Based Mental Evaluation and Diagnosis

  • 홍성규 (경희대학교 대학원 한방신경정신과) ;
  • 이현우 (경희대학교 대학원 한방신경정신과) ;
  • 정선용 (경희대학교 한의과대학 한방신경정신과학교실) ;
  • 김종우 (경희대학교 한의과대학 한방신경정신과학교실)
  • Sunggyu, Hong (Department of Neuropsychiatry, Graduate School, Kyung Hee University) ;
  • Hyun Woo, Lee (Department of Neuropsychiatry, Graduate School, Kyung Hee University) ;
  • Sun-Yong, Chung (Department of Neuropsychiatry, College of Korean Medicine, Kyung Hee University) ;
  • Jong-Woo, Kim (Department of Neuropsychiatry, College of Korean Medicine, Kyung Hee University)
  • 투고 : 2022.09.27
  • 심사 : 2022.11.22
  • 발행 : 2022.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: For diagnosis and evaluation, evaluation tools are needed. Various tools can be used to diagnose and evaluate mental disorders. Among them, psychological tests are widely used. For Korean Standard Classification of Diseases (KCD) diagnosis, psychological tests are also required. Currently developed critical pathway (CP) presented tools for diagnosis and evaluation of mental disorders. The CP suggests the use of tools based on the Clinical Practice Guideline (CPG). Therefore, CPG-based tools should be able to be used in the clinical scene of Korean Medicine for diagnosing and evaluating mental disorders according to CP. Methods: Tools suggested by CPs are summarized. The degree of utilization of tools in CPGs is also summarized. A review was conducted by Korean Medicine neuropsychiatrist experts on tools and user's usage plan. Results: As a result, developed CPs suggested using 19 tools for anxiety disorder, 13 tools for insomnia), 12 tools for Hwabyeong, and 9 tools for dementia. In CPG, 48, 34, 44, and 44 tools were used for anxiety disorder, insomnia, Hwabyeong, and dementia, respectively. Among tools presented in CP, HAM-A, HAM-D, CGI, SAS, and TESS for anxiety disorder, CPG, ISI, and PSQI for insomnia disorder, CPG, STAI, and STAXI for Hwabyeong were frequently used in CPG. For dementia CPG, MoCA, MMSE, HDS, ADL, and ADAS-cog were frequently used. Among them, MoCA, ADL, and ADAS-cog were suggested tools in CP. Conclusions: As a result of analyzing tools suggested and used in the developed CPs and CPGs, it was verified that various tools were used in each study. Most of them were symptom and behavioral evaluation scales. Therefore, symptoms and behavior evaluation scales used more frequently should be able to be used in the clinical scene of Korean Medicine.

키워드

참고문헌

  1. National Oriental Medical College Neuropsychology Textbook Compilation Committee. Korean Neuropsychology. Seoul: Jipmoondang; 2018.
  2. Kim TW. Quality assessment of outpatient depression care. Health Insurance Review & Assessment Service. 2020;14(2):56-78.
  3. Yim HJ, Kim SH, Lee SR, et al. Study to develop the instrument of pattern identification for Hwa-byung. Korean Journal of Oriental Physiology & Pathology. 2008;22(5):1071-7.
  4. Lee EH, Choi WC, Jung IC. Preliminary study to develop the instrument on pattern identifications for depression. Journal of Oriental Neuropsychiatry. 2013;24(4):435-50. https://doi.org/10.7231/JON.2013.24.4.435
  5. Ryu CH, Jung IC, Cho SH, et al. Preliminary study to develop the instrument of oriental medical evaluation for dementia. Journal of Oriental Neuropsychiatry. 2010;21(4):123-35.
  6. Jeon JH, Lee JY, Kim JY, et al. A pilot study of evaluating the reliability and validity of pattern identification tool for insomnia and analyzing correlation with psychological tests. Journal of Oriental Neuropsychiatry. 2020;31(1):1-12. https://doi.org/10.7231/JON.2020.31.1.001
  7. Nam HW, Kwak MY, Kim Y et al. Regional Base Public Hospital CP Development Methodology (version 1.0). Seoul: Ministry of Health and Welfare; 2015.
  8. Central CP guidelines [Internet]. Seoul: National Medical Center; [cited 2022 Oct 28]. Available from: https://www. nmc.or.kr/nmc/main/contents.do?menuNo=200348
  9. Lee SI. Overview of Critical Pathway for its successful development and implementation in Korea. J Korean Soc Qual Assur Health Care. 1999;6(1):6-11.
  10. The Korean Society of Oriental Neuropsychiatry. Anxiety disorder critical pathway of korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2022.
  11. The Korean Society of Oriental Neuropsychiatry. Anxiety disorder clinical practice guideline of korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2021.
  12. The Korean Society of Oriental Neuropsychiatry. Insomnia disorder critical pathway of korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2022.
  13. The Korean Society of Oriental Neuropsychiatry. Insomnia disorder clinical practice guideline of korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2021.
  14. The Korean Society of Oriental Neuropsychiatry. Hwabyung Critical Pathway of Korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2020.
  15. The Korean Society of Oriental Neuropsychiatry. Hwabyung clinical practice guideline of Korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2021.
  16. The Korean Society of Oriental Neuropsychiatry. Dementia Critical Pathway of Korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2022.
  17. The Korean Society of Oriental Neuropsychiatry. Dementia clinical practice guideline of Korean medicine. Seoul: National Development Institute of Korean Medicine National Agency for Korean Medicine Innovative Technologies Development; 2021.
  18. Busner J, Targume SD. Clinical global impressions scale: applying a research tool in clinical practice. Psychiatry. 2007;4(7):28-37.
  19. Jung SM, Kim MK, Lee JB, et al. Reliability and validity of the Korean version of the psychotic symptom rating scale. Journal of Korean Neuropsychiatric Association. 2007; 46(3):201-12.
  20. Hamilton M. The assessment of anxiety states by rating. British Journal of Medical Psychology. 1959;32(1):50-5. https://doi.org/10.1111/j.2044-8341.1959.tb00467.x
  21. Yi JS, Bae SO, Ahn YM, et al. Validity and reliability of the Korean Version of the Hamilton Depression Rating Scale (K-HDRS). Journal of Korean Neuropsychiatric Association. 2005;44(4):456-65.
  22. Chung CY, Kim DH. Are anxiety and depression distinct? : Exploratory Factor Analysis of Zung's Self-Rating Anxiety and Depression Scales. Korean journal of biological psychiatry. 2013;20(1):21-7.
  23. National Institute of Mental Health. TESS (Treatment Emergent Symptom Scale-Write-in). Psychopharmacol Bull. 1985;21:1069-72.
  24. Deng XY, Kang HY. Clinical observation on panic disorder treated by integrated traditional Chinese and western medicine (Translated from 中西医结合治疗惊恐障碍症临床观察). Journal of Emergency in Traditional Chinese Medicine. 2014;6:1193-4.
  25. Meng YZ. Clinical analysis of panic disorder by tranquilizing therapy combined with traditional Chinese medicine psychotherapy (Translated from 安神定惊法联合中医心理 疗法治疗惊恐障碍的临床分析). Journal of North Pharmacy. 2016;13(7):114-5.
  26. Zhao H, Yang DD, Shi M. Clinical research on post-traumatic stress disorder in a sample size of 240 by integrated traditional chinese and western medicine. Chinese Journal of Basic Medicine in Traditional Chinese Medicine. 2014;2:211-2.
  27. Che LN. Discussion on the effect of acupuncture on patients with generalized anxiety disorder (Translated from 针刺治疗广泛性焦虑症患者的疗效探讨). Medical Journal of Chinese People's Health. 2015;8:86-7.
  28. Gong Y, He NS, Liu R. Efficacy observation of electroacupuncture combined with duloxetine in the treatment of generalized anxiety (Translated from 电针联合度洛西汀治疗广泛性焦虑的疗效观察). Medical Journal of Chinese People's Health. 2012;24(23):2877-99.
  29. Young WC, Song ML, Morin CM. Validation of a Korean version of the insomnia severity index. J Clin Neurol. 2014;10(3):210-5. https://doi.org/10.3988/jcn.2014.10.3.210
  30. Sohn SI, Kim DH, Cho YW. The reliability and validity of the Korean version of the Pittsburgh Sleep Quality Index. Sleep Breath. 2012;16(3):803-12. https://doi.org/10.1007/s11325-011-0579-9
  31. Zhang J. Clinical observation of 35 cases of insomnia with deficiency of both heart and spleen treated by integrated traditional Chinese and western medicine (Translated from 中西医结合治疗心脾两虚型不寐35例临床疗效观察). Health for Everyone. 2019;12:124-5.
  32. Feng H, Liu X, Xu H, et al. Effect of acupuncture and estazolam on episodic memory and sleep structure in patients with chronic insomnia disorder: a randomized controlled trial Chinese Full Text. Chinese Acupuncture & Moxibustion. 2020;40(7):707-12.
  33. Gaudry E, Spielberger CD. Anxiety and intelligence in paired-associate learning. Journal of Educational Psychology. 1970;61:386-401. https://doi.org/10.1037/h0029796
  34. Hahn DW, Lee CH, Tak JG. Standardization of Spielberger State-Trait Anxiety Test. Korea Institute of Psychology Proceedings of the 93' general conference. 1993:505-12.
  35. Hahn DW, Lee CH, Kyum KC. Korean adaptation of the State-Trait Anger Expression Inventory (STAXI-K) : the case of college students. Korean Journal of Health Psychology. 1998;3(1):18-32.
  36. Choi WJ, Lee SG, Son IB, et al. The effects of Sa-am Acupuncture Simpojeongkyeok treatment on Hwa-byung: randomized, patient-assessor blind, placebo-controlled acupuncture, pilot clinical trial. Journal of Oriental Neuropsychiatry. 2011;22(2):1-14.
  37. Kim SH, Park YC, Hong KE, et al. The effect of Bunsimgi-eum on Hwa-byung: randomized, double blind, placebo controlled trial. Journal of ethnopharmacology. 2012;144(2):402-7. https://doi.org/10.1016/j.jep.2012.09.029
  38. Ko YS, Suh JW, Jin JH, et al. CIST (Cognitive Impairment Screening Test) manual. Seoul: Ministry of Health and Welfare National Institute of Dementia; 2021.
  39. Lee JY, Lee DW, Cho SJ, et al. Brief screening for mild cognitive impairment in elderly outpatient clinic: validation of the Korean version of the Montreal Cognitive Assessment. Journal of geriatric psychiatry and neurology. 2008;21(2):104-10. https://doi.org/10.1177/0891988708316855
  40. Kang YW LB, Park JS, et al. A reliability, validity, and normative study of the Korean-Montreal Cognitive Assessment (K-MoCA) as an instrument for screening of vascular cognitive impairment (VCI). The Korean Journal of Clinical Psychology. 2009;28(2):549-62. https://doi.org/10.15842/kjcp.2009.28.2.013
  41. Tombaugh TN, McIntyre NJ. The Mini-Mental State Exam - ination: a comprehensive review. Journal of the American Geriatrics Society. 1992;40(9):922-35. https://doi.org/10.1111/j.1532-5415.1992.tb01992.x
  42. Han JW, Kim TH, Jhoo JH, et al. A normative study of the Mini-Mental State Examination for Dementia Screening (MMSE-DS) and Its Short form(SMMSE-DS) in the Korean elderly. Journal of Korean Geriatric Psychiatry 2010;14(1):27-37.
  43. Kang YW, Na DL, Chung CS, et al. Comparison of two screening tests in dementia: the Mini-Mental State Exam - ination (MMSE) and the revised Hasegawa's Demential Scale (HDS-R). Journal of the Korean Neurological Association. 2009;17:82-3.
  44. Park S, Park BS. Testing reliability and measurement invariance of K-ADL. Health and Social Welfare Review. 2017;37(4):98-124. https://doi.org/10.15709/hswr.2017.37.4.98
  45. Youn JC, Lee DY, Kim KW, et al. Development of the Korean version of Alzheimer's disease assessment scale (ADAS-K). International journal of geriatric psychiatry. 2002;17(9):797-803.
  46. Zhao LY, Wang ZJ, Ma XC, et al. Clinical observation of modified Liuwei Dihuang decoction in the treatment of vascular dementia with elevated high-sensitivity C-reactive protein (Translated from 六味地黄汤加减治疗血管性痴呆伴超敏C反应蛋白升高疗效观察). Hebei Journal of Traditional Chinese Medicine. 2017;1:73-5.
  47. Zhao G. Clinical Study on Modified Tongqiao Huoxue Tang Combined with Routine Treatment for Vascular Dementia. Journal of New Chinese Medicine. 2019;2:70-2.
  48. Li LL, Jiao FY. 50 cases of vascular dementia treated by Huiyangjiuzhen Acupuncture (Translated from 回阳九针法治疗血管性痴呆患者50例). Shaanxi Journal of Traditional Chinese Medicine. 2014;12:1675-7.
  49. National Health for Mental Health. Standard Guidelines for Mental Health Screening Tools and Use in 2020. Seoul: National Health for Mental Health; 2020.
  50. Eom JY, Choi SW. A Study of Clinical Psychologist's Opinion and Practice of Comprehensive Psychological Testing. Korean Journal of Clinical Psychology. 2018;37(1):1-17. https://doi.org/10.15842/KJCP.2018.37.1.001
  51. De Bleser L, Depreitere R, Waele K, et al. Defining pathways. Journal of nursing management. 2006;14(7):553-63.  https://doi.org/10.1111/j.1365-2934.2006.00702.x